Subtype
Brain Neoplasm
CI-CAN-00002030Explore in graph →
Non-malignant512 active trials34 evidence items
Loading cancer entity…
Subtype
CI-CAN-00002030Explore in graph →
Clinical trials
2,118 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07339085 | Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis | recruiting | N/A | 42 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07342686 | Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma | completed | — | 500 | West China HospitalOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07343479 | Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases | not yet recruiting | Phase 2 | 45 | Zhejiang Cancer HospitalOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT00811148 | Florida Center for Brain Tumor Research(FCBTR) | recruiting | — | 4,000 | University of FloridaOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT01535430 | Assessment of Eloquent Function in Brain Tumor Patients | recruiting | — | 75 | University of NebraskaOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT04745156 | A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas | not yet recruiting | N/A | 3 | Medical College of WisconsinOTHER | 0 | Jan 12, 2026 | clinicaltrials |
| NCT07332234 | Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies(EICON) | recruiting | — | 200 | Spitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș"OTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT05106296 | Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer | recruiting | Phase 1 | 37 | Theodore S. JohnsonOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT06799481 | Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors | recruiting | N/A | 60 | Emory UniversityOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT07329634 | Evaluation of Neoadjuvant Stereotactic Radiosurgery (SRS) and Multi-fraction SRS Alone for the Treatment of Large Brain Metastases(RENESANS) | not yet recruiting | Phase 3 | 98 | Maciej HaratOTHER | 0 | Jan 9, 2026 | clinicaltrials |
| NCT07331064 | Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid Tumor(GABRIEL) | not yet recruiting | Phase 1 | 15 | Sarah RumlerOTHER | 0 | Jan 9, 2026 | clinicaltrials |
| NCT04049669 | Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG | active not recruiting | Phase 2 | 130 | Theodore S. JohnsonOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT06936813 | The PROMISE Survey | active not recruiting | — | 530 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT07321262 | Machine Learning to Predict Postoperative Pneumonia in Brain Tumor Patients(ML-PNEUMO-BT) | completed | — | 1,856 | Ming YangOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT04869449 | Neuro-pharmacological Properties of Repurposed Ketoconazole in Glioblastomas | terminated | Early Phase 1 | 1 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07321353 | Survivors Journey+(SJ) | recruiting | N/A | 72 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07323966 | Feasibility of Mask-Free Radiotherapy for Brain Tumor Patients(MASKLESS) | recruiting | N/A | 20 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT06584123 | Molecular Pituitary Imaging Using 18F-FET PET(FET-pit-PET) | recruiting | N/A | 20 | University of CambridgeOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT04295759 | INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas | completed | Phase 1 | 13 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Jan 5, 2026 | clinicaltrials |
| NCT05049148 | Platelets Activation in Brain Neoplasms(Platon) | recruiting | N/A | 50 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 1 | Jan 5, 2026 | clinicaltrials |
| NCT05688683 | Brain Representation of Acquisition in Humans of Motor-Sensory Skills(BRAHMS) | recruiting | — | 50 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 1 | Jan 5, 2026 | clinicaltrials |
| NCT07313709 | Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors. | not yet recruiting | N/A | 40 | University of CincinnatiOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT01266096 | PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study | active not recruiting | N/A | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT05553522 | Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer | terminated | Phase 1 | 1 | Baptist Health South FloridaOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT07307157 | Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review(COSMO) | enrolling by invitation | — | 30 | Harvard Medical School (HMS and HSDM)OTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT04165941 | Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma(DRI) | active not recruiting | Phase 1 | 22 | University of Alabama at BirminghamOTHER | 1 | Dec 26, 2025 | clinicaltrials |
| NCT06322342 | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent | completed | Phase 2 | 18 | Reveal Pharmaceuticals Inc.INDUSTRY | 1 | Dec 26, 2025 | clinicaltrials |
| NCT05503251 | Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases | active not recruiting | Phase 2 | 110 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT05465343 | Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE) | completed | Phase 2 | 24 | Peking Union Medical CollegeOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT04541082 | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms | recruiting | Phase 1 | 102 | Jazz PharmaceuticalsINDUSTRY | 1 | Dec 18, 2025 | clinicaltrials |
| NCT07291102 | Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma | not yet recruiting | Phase 3 | 96 | Nationwide Children's HospitalOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT03500991 | HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors | active not recruiting | Phase 1 | 10 | Seattle Children's HospitalOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT03638167 | EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors | completed | Phase 1 | 11 | Seattle Children's HospitalOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT05259605 | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | recruiting | — | 1,650 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Dec 17, 2025 | clinicaltrials |
| NCT05976490 | NeuroPathways Intervention for Brain Tumor Patients | recruiting | N/A | 50 | Massachusetts General HospitalOTHER | 1 | Dec 17, 2025 | clinicaltrials |
| NCT05686798 | Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. | recruiting | Phase 1 | 18 | Henry Ford Health SystemOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT06898684 | Medulloblastoma Online Video-based Exercise Pilot Study(MOVE) | recruiting | N/A | 15 | Aron OnerupOTHER_GOV | 2 | Dec 16, 2025 | clinicaltrials |
| NCT07286396 | Non-invasive Intracranial Pressure Monitoring in Brain Tumor Patients | not yet recruiting | — | 60 | Tanta UniversityOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT06098248 | Evaluation of cCeLL-Ex Vivo Confocal Microscopy for Real-time Brain Tumor Diagnosis(cCeLLExvivo) | terminated | N/A | 285 | VPIX MedicalINDUSTRY | 2 | Dec 15, 2025 | clinicaltrials |
| NCT02374242 | Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases(ABC) | active not recruiting | Phase 2 | 76 | Melanoma Institute AustraliaOTHER | 1 | Dec 10, 2025 | clinicaltrials |
| NCT04738162 | Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors | completed | Phase 2 | 78 | Universität MünsterOTHER | 2 | Dec 10, 2025 | clinicaltrials |
| NCT05956821 | Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age | recruiting | Phase 1 / Phase 2 | 20 | University of MiamiOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT04106531 | Validation of a Quality of Life Metric "Prolac-10"(Prolac-10) | terminated | — | 8 | Ohio State UniversityOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT02066220 | International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma | active not recruiting | Phase 2 / Phase 3 | 360 | Universitätsklinikum Hamburg-EppendorfOTHER | 16 | Dec 4, 2025 | clinicaltrials |
| NCT02238899 | Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma | completed | — | 354 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT02417324 | International HIT-MED Registry (I-HIT-MED) | recruiting | — | 500 | Universitätsklinikum Hamburg-EppendorfOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04306484 | 18F-DOPA-PET in Non-tumoral and Tumoral Brain Lesions(FDOPA) | completed | — | 74 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04503772 | Preoperative Stereotactic Radiosurgery for Brain Metastases(STEP) | completed | Phase 2 | 70 | Centre Jean PerrinOTHER | 1 | Dec 4, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Jan 15, 2026source: clinicaltrials